Volker Berl

Volker Berl is the current Director at OrthogenRx, and was previously with Artract Medical Inc., Standard Lithium, Emoshape INC, BrainCheck, Venock Medical GmbH, Leaderlease S.A., and OrthogenRx. Volker has also been the Managing Partner & CEO at New Age Ventures, and a Member of the Board of Directors at GAUSSIN GROUP.

Volker Berl has a Ph.D. in Supramolecular Chemistry from the University of Strasbourg, an M.B.A. in Business Administration and General Management from Concordia University, and is an Ingénieur in Chemistry and Chemical Engineering from ECPM Ecole européenne de chimie polymères et matériaux de Strasbourg. Volker also has a M.Sc. in Organic Chemistry from ETH Zürich and a B.Sc. in General Chemistry from Karlsruhe Institute of Technology (KIT).